Literature DB >> 11274359

Lack of tissue glucocorticoid reactivation in 11beta -hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments.

J L Yau1, J Noble, C J Kenyon, C Hibberd, Y Kotelevtsev, J J Mullins, J R Seckl.   

Abstract

11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD-1) intracellularly regenerates active corticosterone from circulating inert 11-dehydrocorticosterone (11-DHC) in specific tissues. The hippocampus is a brain structure particularly vulnerable to glucocorticoid neurotoxicity with aging. In intact hippocampal cells in culture, 11beta-HSD-1 acts as a functional 11beta-reductase reactivating inert 11-DHC to corticosterone, thereby potentiating kainate neurotoxicity. We examined the functional significance of 11beta-HSD-1 in the central nervous system by using knockout mice. Aged wild-type mice developed elevated plasma corticosterone levels that correlated with learning deficits in the watermaze. In contrast, despite elevated plasma corticosterone levels throughout life, this glucocorticoid-associated learning deficit was ameliorated in aged 11beta-HSD-1 knockout mice, implicating lower intraneuronal corticosterone levels through lack of 11-DHC reactivation. Indeed, aged knockout mice showed significantly lower hippocampal tissue corticosterone levels than wild-type controls. These findings demonstrate that tissue corticosterone levels do not merely reflect plasma levels and appear to play a more important role in hippocampal functions than circulating blood levels. The data emphasize the crucial importance of local enzymes in determining intracellular glucocorticoid activity. Selective 11beta-HSD-1 inhibitors may protect against hippocampal function decline with age.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11274359      PMCID: PMC31900          DOI: 10.1073/pnas.071562698

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons.

Authors:  C S Woolley; E Gould; B S McEwen
Journal:  Brain Res       Date:  1990-10-29       Impact factor: 3.252

2.  Hippocampal cell death.

Authors:  P W Landfield; B S McEwan; R M Sapolsky; M J Meaney
Journal:  Science       Date:  1996-05-31       Impact factor: 47.728

3.  Hippocampal lesions cause learning deficits in inbred mice in the Morris water maze and conditioned-fear task.

Authors:  S F Logue; R Paylor; J M Wehner
Journal:  Behav Neurosci       Date:  1997-02       Impact factor: 1.912

Review 4.  Modulation of brain aging correlates by long-term alterations of adrenal steroids and neurally-active peptides.

Authors:  P W Landfield
Journal:  Prog Brain Res       Date:  1987       Impact factor: 2.453

5.  Effect of neonatal handling on age-related impairments associated with the hippocampus.

Authors:  M J Meaney; D H Aitken; C van Berkel; S Bhatnagar; R M Sapolsky
Journal:  Science       Date:  1988-02-12       Impact factor: 47.728

6.  Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11beta-HSD-1-deficient mice.

Authors:  H J Harris; Y Kotelevtsev; J J Mullins; J R Seckl; M C Holmes
Journal:  Endocrinology       Date:  2001-01       Impact factor: 4.736

7.  Basal cortisol levels and cognitive deficits in human aging.

Authors:  S Lupien; A R Lecours; I Lussier; G Schwartz; N P Nair; M J Meaney
Journal:  J Neurosci       Date:  1994-05       Impact factor: 6.167

8.  Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation.

Authors:  B R Walker; A A Connacher; R M Lindsay; D J Webb; C R Edwards
Journal:  J Clin Endocrinol Metab       Date:  1995-11       Impact factor: 5.958

9.  Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma.

Authors:  J F Dunn; B C Nisula; D Rodbard
Journal:  J Clin Endocrinol Metab       Date:  1981-07       Impact factor: 5.958

10.  Analysis of severe photoreceptor loss and Morris water-maze performance in aged rats.

Authors:  W K O'Steen; R L Spencer; D J Bare; B S McEwen
Journal:  Behav Brain Res       Date:  1995-06       Impact factor: 3.332

View more
  53 in total

1.  Modulation of 11beta-hydroxysteroid dehydrogenase type 1 activity by 1,5-substituted 1H-tetrazoles.

Authors:  Scott P Webster; Margaret Binnie; Kirsty M M McConnell; Karen Sooy; Peter Ward; Michael F Greaney; Andy Vinter; T David Pallin; Hazel J Dyke; Matthew I A Gill; Ines Warner; Jonathan R Seckl; Brian R Walker
Journal:  Bioorg Med Chem Lett       Date:  2010-04-18       Impact factor: 2.823

Review 2.  Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in obesity.

Authors:  Deborah J Wake; Brian R Walker
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

3.  Aging and stress: past hypotheses, present approaches and perspectives.

Authors:  Pedro Garrido
Journal:  Aging Dis       Date:  2011-01-28       Impact factor: 6.745

Review 4.  11beta-HSD1, inflammation, metabolic disease and age-related cognitive (dys)function.

Authors:  Karen E Chapman; Jonathan R Seckl
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

5.  Role of the flocculus in mediating vestibular nucleus neuron plasticity during vestibular compensation in the rat.

Authors:  Alex R Johnston; Jonathan R Seckl; Mayank B Dutia
Journal:  J Physiol       Date:  2002-12-15       Impact factor: 5.182

Review 6.  The biological actions of dehydroepiandrosterone involves multiple receptors.

Authors:  Stephanie J Webb; Thomas E Geoghegan; Russell A Prough; Kristy K Michael Miller
Journal:  Drug Metab Rev       Date:  2006       Impact factor: 4.518

7.  11beta-hydroxysteroid dehydrogenase type 1 expression is increased in the aged mouse hippocampus and parietal cortex and causes memory impairments.

Authors:  Megan C Holmes; Roderick N Carter; June Noble; Shruti Chitnis; Amy Dutia; Janice M Paterson; John J Mullins; Jonathan R Seckl; Joyce L W Yau
Journal:  J Neurosci       Date:  2010-05-19       Impact factor: 6.167

8.  11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics.

Authors:  Thekkepat C Sandeep; Joyce L W Yau; Alasdair M J MacLullich; June Noble; Ian J Deary; Brian R Walker; Jonathan R Seckl
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-07       Impact factor: 11.205

Review 9.  11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes.

Authors:  T M Stulnig; W Waldhäusl
Journal:  Diabetologia       Date:  2003-12-03       Impact factor: 10.122

10.  Hypothalamic-pituitary-adrenal axis abnormalities in response to deletion of 11beta-HSD1 is strain-dependent.

Authors:  R N Carter; J M Paterson; U Tworowska; D J Stenvers; J J Mullins; J R Seckl; M C Holmes
Journal:  J Neuroendocrinol       Date:  2009-07-07       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.